CTRV News and Press, ContraVir Pharmaceuticals Inc. From 06/20/19

ContraVir Pharmaceuticals (NASDAQ: CTRV )  announces receiving positive FDA feedback to its pre-IND meeting for developing CRV431 in NASH. More news on: ContraVir Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

EDISON, N.J., June 20, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral i...

Gainers:  Roan Resources (NYSE: ROAN ) +44% . Arbutus Biopharma Corporation (NASDAQ: ABUS ) +42% . China Internet Nationwide Financial Services (NASDAQ: CIFS ) +28% . DiaMedica Therapeutics (NASDAQ: DMAC ) +27% . B Communications (NASDAQ: BCOM ) +24% . Hebron Technology (NASDAQ: ...

Gainers:  Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...

ContraVir Pharmaceuticals ( CTRV -44.6% ) plunges to cap off a whipsaw week that included encouraging results of drug studies and SEC filings showing the withdrawal, and the withdrawal of the withdrawal, of a share offering. More news on: ContraVir Pharmaceuticals, Inc., Healthcare sto...

Gainers:  MoneyGram International (NASDAQ: MGI ) +106% . China Internet Nationwide Financial Services (NASDAQ: CIFS ) +33% . G1 Therapeutics (NASDAQ: GTHX ) +26% . SunPower Corporation (NASDAQ: SPWR ) +24% . Sundance Energy Australia (NASDAQ: SNDE ) +20% . Cortexyme (NASDAQ: CRTX...

Digital Ally (NASDAQ: DGLY )  -42%  on Axon patent win. More news on: Digital Ally, Inc., ContraVir Pharmaceuticals, Inc., Biohaven Pharmaceutical Holding Company Ltd., Stocks on the move, Read more ...

EDISON, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (“ContraVir,” the “Company,” “we,” “our” or “us”) (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs ...

Gainers:  Sotheby's (NYSE: BID ) +58% . Array BioPharma (NASDAQ: ARRY ) +57% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +42% . Vislink Technologies (NASDAQ: VISL ) +40% . MTech Acquisition (NASDAQ: MTEC ) +34% . Endurance International Group Holdings (NASDAQ: EIGI ) +26% . C&am...

ContraVir Pharmaceuticals ( CTRV +40% ) surges after reporting " compelling positive results " from experiments involving the company's CRV431 drug candidate for the treatment of liver disease arising from non-alcoholic steatohepatitis and chronic viral infection. More news on: ContraVir...